Article Information
History
- May 19, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Mohammad Mirzakhani1,2,
- Safa Tahmasebi3,
- Mohammadreza Dashti2,4,
- Mohammad Reza Mohammadi5,
- Manizhe Faghih6,
- Mousa Mohammadnia-Afrouzi7,
- Hadi Esmaeili Gouvarchin Ghaleh8 and
- Jafar Amani1,*
- 1Applied Microbiology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran
- 2Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran
- 3Department of Immunology, School of Medicine, Shahid beheshti University of Medical Sciences, Tehran, Iran
- 4Department of Immunology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
- 5Department of Bacteriology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
- 6Department of Immunology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
- 7Immunoregulation Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
- 8Applied Virology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran
- ↵*Corresponding Author: Dr. Jafar Amani. Applied Microbiology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Vanak Sq. Molasadra St. Tehran- Iran. P.O. Box 19395-5487., Tel: +98 21 82482556, Fax: +98 21 88068924. Email: jafar.amani{at}gmail.com
Posted May 19, 2022.
Evaluation of anti-spike glycoprotein antibody and neutralizing antibody response of different vaccine platforms. A protocol of systematic review and meta-analysis of COVID-19 vaccine clinical trial studies
